Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,151 | 395 | 99.1% |
| Education | $58.79 | 10 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $980.93 | 56 | $0 (2022) |
| PFIZER INC. | $686.86 | 53 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $504.26 | 44 | $0 (2020) |
| GlaxoSmithKline, LLC. | $371.64 | 25 | $0 (2022) |
| Lilly USA, LLC | $358.23 | 18 | $0 (2019) |
| ABBVIE INC. | $343.86 | 17 | $0 (2022) |
| Astellas Pharma US Inc | $303.22 | 18 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $196.10 | 16 | $0 (2021) |
| Novo Nordisk Inc | $195.14 | 11 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $194.08 | 15 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $336.09 | 17 | Boehringer Ingelheim Pharmaceuticals, Inc. ($98.37) |
| 2021 | $387.18 | 21 | Boehringer Ingelheim Pharmaceuticals, Inc. ($142.21) |
| 2020 | $386.21 | 23 | Boehringer Ingelheim Pharmaceuticals, Inc. ($64.97) |
| 2019 | $1,694 | 114 | PFIZER INC. ($297.72) |
| 2018 | $1,922 | 119 | Boehringer Ingelheim Pharmaceuticals, Inc. ($292.21) |
| 2017 | $1,485 | 111 | Boehringer Ingelheim Pharmaceuticals, Inc. ($221.80) |
All Payment Transactions
405 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/29/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: DIABETES | ||||||
| 04/25/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $14.28 | General |
| Category: Cardiovascular | ||||||
| 04/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: RESPIRATORY | ||||||
| 04/20/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/18/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: VACCINES | ||||||
| 04/13/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/06/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Diabetes Care | ||||||
| 04/04/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Diabetes Care | ||||||
| 03/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Cardio-renal | ||||||
| 02/18/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: DIABETES | ||||||
| 02/07/2022 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/21/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/20/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: DIABETES | ||||||
| 01/10/2022 | Amryt Pharma Holdings Ltd | MYCAPSSA (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Endocrinology | ||||||
| 01/07/2022 | EISAI INC. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $18.04 | General |
| Category: Neurology | ||||||
| 12/06/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: DIABETES | ||||||
| 11/19/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: DIABETES | ||||||
| 11/15/2021 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Diabetes Care | ||||||
| 10/29/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $0.20 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: DIABETES | ||||||
| 10/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 212 | 229 | $35,093 | $13,387 |
| 2021 | 13 | 1,285 | 1,539 | $187,022 | $103,631 |
| 2020 | 12 | 997 | 1,277 | $161,555 | $78,111 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 39 | 39 | $7,800 | $5,622 | 72.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 86 | $16,340 | $5,064 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 63 | $8,288 | $2,447 | 29.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 41 | 41 | $2,665 | $253.36 | 9.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 234 | 234 | $46,800 | $34,000 | 72.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 177 | 321 | $60,990 | $31,277 | 51.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 239 | 321 | $40,446 | $20,189 | 49.9% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 114 | 114 | $6,840 | $4,959 | 72.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 74 | 74 | $6,645 | $4,825 | 72.6% |
| 0031A | Adm sarscov2 vac ad26 .5ml | Office | 2021 | 54 | 54 | $3,240 | $2,349 | 72.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 154 | 162 | $10,530 | $1,652 | 15.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 80 | 80 | $3,600 | $1,482 | 41.2% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $2,005 | $1,373 | 68.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 13 | 16 | $2,960 | $746.56 | 25.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 11 | 28 | $2,380 | $536.55 | 22.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 13 | 13 | $585.00 | $240.49 | 41.1% |
| 91301 | Sarscov2 vac 100mcg/0.5ml im | Office | 2021 | 111 | 111 | $1.11 | $1.11 | 100.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 186 | 186 | $35,400 | $23,722 | 67.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 248 | 355 | $44,730 | $17,775 | 39.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 132 | 213 | $40,470 | $17,058 | 42.1% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 96 | 97 | $7,275 | $5,909 | 81.2% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 13 | 101 | $8,585 | $3,304 | 38.5% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 27 | 27 | $4,590 | $3,198 | 69.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 104 | 105 | $4,725 | $1,924 | 40.7% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 11 | 11 | $3,300 | $1,714 | 51.9% |
About Dr. Neil Wasserman, M.D
Dr. Neil Wasserman, M.D is a Internal Medicine healthcare provider based in New Britain, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285621250.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Neil Wasserman, M.D has received a total of $6,210 in payments from pharmaceutical and medical device companies, with $336.09 received in 2022. These payments were reported across 405 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($6,151).
As a Medicare-enrolled provider, Wasserman has provided services to 2,494 Medicare beneficiaries, totaling 3,045 services with total Medicare billing of $195,129. Data is available for 3 years (2020–2022), covering 29 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location New Britain, CT
- Active Since 10/04/2005
- Last Updated 07/09/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1285621250
Products in Payments
- JARDIANCE (Drug) $542.34
- CHANTIX (Drug) $360.67
- INVOKANA (Drug) $265.21
- XARELTO (Drug) $239.05
- XIFAXAN (Drug) $235.96
- BASAGLAR (Drug) $191.50
- Vascepa (Drug) $183.00
- SPIRIVA RESPIMAT (Drug) $173.40
- FARXIGA (Drug) $165.53
- Synthroid (Drug) $163.67
- SHINGRIX (Biological) $163.57
- VESICARE (Drug) $152.92
- STIOLTO (Drug) $146.35
- Ozempic (Drug) $139.42
- MYRBETRIQ (Drug) $134.80
- Prolia (Biological) $127.77
- JANUVIA (Drug) $127.76
- PREVNAR - 13 (Biological) $119.08
- TRADJENTA (Drug) $118.35
- NUEDEXTA (Drug) $115.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New Britain
Dr. Joseph Rosenblatt, M.d, M.D
Internal Medicine — Payments: $531,879
Dr. Yousong Wang, M.d, M.D
Internal Medicine — Payments: $35,633
Dr. Arun Agarwal, M.d, M.D
Internal Medicine — Payments: $17,914
Dr. Michael Honor, M.d, M.D
Internal Medicine — Payments: $15,103
Dr. Mark Piekarsky, M.d, M.D
Internal Medicine — Payments: $12,088
Dr. Wael Elmallah, Md, Msc, Phd, MD, MSC, PHD
Internal Medicine — Payments: $11,704